Concepedia

Ángela Lamarca

ÁL

77

Publications

4.8K

Citations

33

H-Index

2010

Active since

Affiliations

The Christie NHS Foundation Trust(Current)

University of Manchester

Cancer Research UK Manchester Institute

University College London

Manchester Academic Health Science Centre

Ángela Lamarca is an author at The Christie NHS Foundation Trust specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2010–2024

77

Publications

77

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan et al. · The Lancet Oncology · 2021 · 711 citations · Full text

Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Thierry Conroy, Per Pfeiffer, Valérie Vilgrain et al. · Annals of Oncology · 2023 · 413 citations · Full text

, , +7

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

Laura Izquierdo‐Sánchez, Ángela Lamarca, Adelaida La Casta et al. · Journal of Hepatology · 2022 · 322 citations · Full text

Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

Colin Hutton, Felix Heider, Adrián Blanco‐Gómez et al. · Cancer Cell · 2021 · 304 citations · Full text

ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.

Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan et al. · Journal of Clinical Oncology · 2019 · 226 citations

, , +17

Rows per page

1–5 of 77